MDLZ
28
2
CMCSA
49
3
JNJ
30
4
KEY
24
2
PBI
30
-8
DG
14
6
GWW
50
9
HBI
53
4
CINF
24
-8
MAR
57
3
BDX
59
3
UA
48
6
HAS
29
3
VRSN
59
4
PSA
43
6
UPS
51
6
HPQ
55
3
IBM
53
2
DFS
64
4
GM
55
6
MDLZ
28
2
CMCSA
49
3
JNJ
30
4
KEY
24
2
PBI
30
-8
DG
14
6
GWW
50
9
HBI
53
4
CINF
24
-8
MAR
57
3
BDX
59
3
UA
48
6
HAS
29
3
VRSN
59
4
PSA
43
6
UPS
51
6
HPQ
55
3
IBM
53
2
DFS
64
4
GM
55
6
Financhill
Back

Rivian Automotive 10K Form

Buy
67

RIVN
Rivian Automotive

Last Price:
$13.85
Seasonality Move:
-48.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RIVN News And Ratings

See the #1 stock for the next 7 days that we like better than RIVN

RIVN Financial Statistics

Sales & Book Value

Annual Sales: $4.4B
Cash Flow: $-1.2B
Price / Cash Flow: 0
Annual Sales: $5.73
Price / Book: 2.39

Profitability

EPS (TTM): -5.60000
Net Income (TTM): $-5.5B
Gross Margin: $-2B
Return on Equity: -68.23%
Return on Assets: -35.15%

Rivian Automotive Earnings Forecast

Key Rivian Automotive Financial Ratios

  • The Gross Profit Margin over the past 5 years for RIVN is -45.78%.
  • The Selling, General & Administrative Expenses for RIVN have been equal to 38.66% of Gross Profit Margin.
  • The Research & Development expenses have been 44.99% of Revenue.
  • The Interest Expense is -4.05% of Operating Income.
  • The Net Earning history of RIVN is -122.51% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Rivian Automotive Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Automobiles
Sector: Consumer Discretionary
Current Symbol: RIVN
Website: rivian.com

Debt

Debt-to-Equity Ratio: 0.93
Current Ratio: 5.09
Quick Ratio: 3.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RIVN Technical Analysis vs Fundamental Analysis

Buy
67
Rivian Automotive (RIVN) is a Buy

Is Rivian Automotive a Buy or a Sell?

  • Rivian Automotive stock is rated a Buy
    The current Rivian Automotive [RIVN] share price is $13.83. The Score for RIVN is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.